Magnetic resonance spectroscopy of the breast: current status.

[1]  Matthias Dietzel,et al.  Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis. , 2013, Radiology.

[2]  T. Coşkun,et al.  Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases. , 2012, Diagnostic and interventional radiology.

[3]  Hee Jung Shin,et al.  Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS , 2012, NMR in biomedicine.

[4]  S. Posse,et al.  Quantitative mapping of total choline in healthy human breast using proton echo planar spectroscopic imaging (PEPSI) at 3 Tesla , 2012, Journal of magnetic resonance imaging : JMRI.

[5]  N Houssami,et al.  Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. , 2012, Breast.

[6]  U. Sharma,et al.  Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: An MRI and in vivo proton MRS study , 2012, Magnetic resonance in medicine.

[7]  Peter R Luijten,et al.  Quantitative 31P magnetic resonance spectroscopy of the human breast at 7 T , 2012, Magnetic resonance in medicine.

[8]  L. Esserman,et al.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. , 2012, Radiology.

[9]  C. Kappas,et al.  Magnetic Resonance Spectroscopy of the Breast at 3T: Pre- and Post-Contrast Evaluation for Breast Lesion Characterization , 2012, TheScientificWorldJournal.

[10]  H. Baek.  Diagnostic Value of Breast Proton Magnetic Resonance Spectroscopy at 1.5T in Different Histopathological Types , 2012, TheScientificWorldJournal.

[11]  H. Kawai,et al.  1H‐magnetic resonance spectroscopy of the breast at 3.0‐T: Comparison of results obtained before and after administration of gadolinium‐based contrast agent , 2012, Journal of Magnetic Resonance Imaging.

[12]  W. Kaiser,et al.  Effect of contrast agent on the results of in vivo 1H MRS of breast tumors – is it clinically significant? , 2012, NMR in biomedicine.

[13]  T. Saeki,et al.  1H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches , 2012, European Radiology.

[14]  Wendy Bruening,et al.  Noninvasive Diagnostic Tests for Breast Abnormalities: Update of a 2006 Review , 2012 .

[15]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[16]  Cecilia Possanzini,et al.  31P MRSI and 1H MRS at 7 T: initial results in human breast cancer , 2011, NMR in biomedicine.

[17]  T. Helbich,et al.  Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. , 2011, Radiology.

[18]  Z. Bhujwalla,et al.  Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.

[19]  T. Bathen,et al.  In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response , 2011, Magnetic Resonance Materials in Physics, Biology and Medicine.

[20]  C. Sirlin,et al.  In vivo characterization of the liver fat 1H MR spectrum , 2011, NMR in biomedicine.

[21]  M. Su,et al.  In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients , 2011, NMR in biomedicine.

[22]  M. Oudkerk,et al.  Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions. , 2011, Radiology.

[23]  Peter R Luijten,et al.  Feasibility of 7 Tesla Breast Magnetic Resonance Imaging Determination of Intrinsic Sensitivity and High-Resolution Magnetic Resonance Imaging, Diffusion-Weighted Imaging, and 1H-Magnetic Resonance Spectroscopy of Breast Cancer Patients Receiving Neoadjuvant Therapy , 2011, Investigative radiology.

[24]  Wei Huang,et al.  Diagnostic usefulness of water‐to‐fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: An in vivo 1H MRS study , 2011, Journal of magnetic resonance imaging : JMRI.

[25]  T. Bathen,et al.  HR MAS MR spectroscopy in metabolic characterization of cancer. , 2011, Current topics in medicinal chemistry.

[26]  D. Bluemke,et al.  Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. , 2010, Academic radiology.

[27]  L. Bassett,et al.  Combined DCE‐MRI and single‐voxel 2D MRS for differentiation between benign and malignant breast lesions , 2010, NMR in biomedicine.

[28]  A. Padhani,et al.  Multiparametric imaging of tumor response to therapy. , 2010, Radiology.

[29]  Saadallah Ramadan,et al.  Neurospectroscopy: the past, present and future. , 2010, Chemical reviews.

[30]  U. Sharma,et al.  Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI) , 2010, NMR in biomedicine.

[31]  M. Tozaki,et al.  Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method , 2010, Journal of magnetic resonance imaging : JMRI.

[32]  M. Oudkerk,et al.  Quantitative multivoxel proton chemical shift imaging of the breast. , 2010, Magnetic resonance imaging.

[33]  Donald B. Plewes,et al.  Evaluation of multicoil breast arrays for parallel imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[34]  M. Tozaki,et al.  Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging , 2010, Japanese Journal of Radiology.

[35]  E. Haacke,et al.  A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3T. , 2009, Medical physics.

[36]  Zenon Starčuk,et al.  Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package , 2009 .

[37]  M. Tozaki,et al.  1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? , 2009, AJR. American journal of roentgenology.

[38]  Hon J. Yu,et al.  Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. , 2009, Radiology.

[39]  R. Lenkinski,et al.  Interaction of gadolinium‐based MR contrast agents with choline: Implications for MR spectroscopy (MRS) of the breast , 2009, Magnetic resonance in medicine.

[40]  F. Podo,et al.  In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. , 2009, AJR. American journal of roentgenology.

[41]  Michael Garwood,et al.  Metabolite quantification and high‐field MRS in breast cancer , 2009, NMR in biomedicine.

[42]  Y. Ogawa,et al.  Choline by magnetic spectroscopy and dynamic contrast enhancement curve by magnetic resonance imaging in neoadjuvant chemotherapy for invasive breast cancer. , 2008, Molecular medicine reports.

[43]  Daniel B. Vigneron,et al.  Advances in MR spectroscopy of the prostate. , 2008, Magnetic resonance imaging clinics of North America.

[44]  Hon J. Yu,et al.  Detection of choline signal in human breast lesions with chemical‐shift imaging , 2008, Journal of magnetic resonance imaging : JMRI.

[45]  Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[46]  M. Pickles,et al.  Lesion T(2) relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy. , 2008, Magnetic resonance imaging.

[47]  Wei Huang,et al.  Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. , 2007, Radiology.

[48]  Peter Stanwell,et al.  In vivo proton MR spectroscopy of the breast. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[49]  N. Jagannathan,et al.  Monitoring the therapeutic response of locally advanced breast cancer patients: Sequential in vivo proton MR spectroscopy study , 2006, Journal of magnetic resonance imaging : JMRI.

[50]  Dmitriy A Yablonskiy,et al.  Natural linewidth chemical shift imaging (NL‐CSI) , 2006, Magnetic resonance in medicine.

[51]  Wei Huang,et al.  Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. , 2006, Radiology.

[52]  L. Turnbull,et al.  Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy , 2006, British Journal of Cancer.

[53]  K. Brandt,et al.  Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. , 2005, Radiology.

[54]  K. Bae,et al.  Evaluation of 1H-Magnetic Resonance Spectroscopy of Breast Cancer Pre- and Postgadolinium Administration , 2005, Investigative radiology.

[55]  B. Tomanek,et al.  Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T , 2005, European Radiology.

[56]  Michael Garwood,et al.  Measurement and correction of respiration‐induced B0 variations in breast 1H MRS at 4 Tesla , 2004, Magnetic resonance in medicine.

[57]  D. Yee,et al.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. , 2004, Radiology.

[58]  Ewald Moser,et al.  Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas , 2004, NeuroImage.

[59]  Wei Huang,et al.  Detection of breast malignancy: diagnostic MR protocol for improved specificity. , 2004, Radiology.

[60]  Arend Heerschap,et al.  Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.

[61]  R. Lenkinski,et al.  Frame‐by‐frame PRESS 1H‐MRS of the brain at 3 T: The effects of physiological motion , 2004, Magnetic resonance in medicine.

[62]  D. Bluemke,et al.  Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study , 2004, Journal of magnetic resonance imaging : JMRI.

[63]  Robert E. Lenkinski,et al.  The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy , 2001, Breast Cancer Research and Treatment.

[64]  Michael Garwood,et al.  In vivo quantification of choline compounds in the breast with 1H MR spectroscopy , 2003, Magnetic resonance in medicine.

[65]  Winnie C W Chu,et al.  Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. , 2003, AJR. American journal of roentgenology.

[66]  Sung-Hwan Park,et al.  In vivo 1H-MRS evaluation of malignant and benign breast diseases. , 2003, Breast.

[67]  Daniel B Vigneron,et al.  In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI , 2002, Journal of magnetic resonance imaging : JMRI.

[68]  Wei-Tse Yang,et al.  Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. , 2002, Radiology.

[69]  R. Lenkinski,et al.  Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. , 2002, Journal of the National Cancer Institute.

[70]  Hellmut Merkle,et al.  Eliminating spurious lipid sidebands in 1H MRS of breast lesions , 2002, Magnetic resonance in medicine.

[71]  Donald B Plewes,et al.  Comparison of MR imaging breast coils. , 2002, Radiology.

[72]  I. Gribbestad,et al.  External standard method for the in vivo quantification of choline‐containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla , 2001, Magnetic resonance in medicine.

[73]  D. Yeung,et al.  Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results. , 2001, Radiology.

[74]  R. Goebel,et al.  7T vs. 4T: RF power, homogeneity, and signal‐to‐noise comparison in head images , 2001, Magnetic resonance in medicine.

[75]  S. Dwivedi,et al.  Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer , 2001, British Journal of Cancer.

[76]  D. Hoult.  Sensitivity and Power Deposition in a High‐Field Imaging Experiment , 2000, Journal of magnetic resonance imaging : JMRI.

[77]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[78]  I. Gribbestad,et al.  Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[79]  V. Govindaraju,et al.  Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water–fat ratio in patients receiving chemotherapy , 1998, NMR in biomedicine.

[80]  K. Uğurbil,et al.  Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. , 1998, Journal of magnetic resonance.

[81]  R. Lenkinski,et al.  Human breast lesions: characterization with proton MR spectroscopy. , 1998, Radiology.

[82]  J. Granot.  Selected volume spectroscopy (SVS) and chemical-shift imaging. A comparison , 1986 .